The hunt continues for novel antiviral agents especially against the pandemic H1N1 virus. In this article, a drug that has been used to fight HIV infection and vesicular stomatitis now appears to have the potential to block influenzavirus infection by inhibiting neuraminidase. This may be yet another positive step in the battle against flu.